A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma
Clinical trial NCT04712097 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04712097
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-27
- Primary completion
- 2026-06-03
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.